Climacteric in anxiety: prevalence and associated factors

Authors

  • Wendry Maria Paixão Pereira Universidade de São Paulo; Faculdade Saúde Pública; Departamento de Saúde Materno-Infantil
  • Ana Carolina Basso Schmitt Universidade de São Paulo; Faculdade Saúde Pública; Departamento de Saúde Materno-Infantil
  • Cássia Maria Buchalla Universidade de São Paulo; Faculdade de Saúde Pública; Departamento de Epidemiologia
  • Alberto Olavo Advincula Reis Universidade de São Paulo; Faculdade de Saúde Pública; Departamento de Epidemiologia
  • José Mendes Aldrighi Universidade de São Paulo; Faculdade Saúde Pública; Departamento de Saúde Materno-Infantil

DOI:

https://doi.org/10.7322/jhgd.19905

Keywords:

anxiety, climacteric, menopause, postmenopause

Abstract

The present study estimated the prevalence of anxiety and characterized the possible associated factors in 749 women in menopause, registered in the Family Health Program and members of the Project of Health Pindamonhangaba (PROSAPIN). This is a cross sectional observational study, the method was the application of a self-reported questionnaire containing socio-demographic variables of anxiety and anthropometry. Statistical analysis was performed by the distribution of frequencies and Odds Ratio (confidence interval=95%), considering the level of significance at p>;0.05. The results showed that the prevalence of anxiety was 49.8% (95% CI: 46.2 to 53.4) and, among the main factors associated with the anxiety of such a school (OR:1,20 p=0.005), activity (OR:0.68 p=0.001) and duration of menopausal transition (OR:1.21 p=0.003). In conclusion, the anxiety was very prevalent, affecting almost half the population studied and the main factors associated with anxiety were the living habits and socioeconomic.

Downloads

Download data is not yet available.

References

Notelovitz M. Climacteric medicine and science: a societal need. in: notelovitz m, ed. The climacteric in perspective. lancaster, 1988:19-21.

Soules MR, Sherman S, Parrott E, Rebar R, Santoro N, Utian W, Woods N. Executive summary: Stages of Reproductive Aging Workshop (STRAW)Climacteric. 2001;4(4):267-72.

Gracia CR, Sammel MD, Freeman EW, Lin H, Langan E, Kapoor S, Nelson DB. Defining menopause status: creation of a new definition to identify the changes of the menopause transition. Menopause. 2005; 2(2):128-135.

Aldrighi JM, Aldrighi CMS, Aldrigh APS. Alterações sistêmicas no climatério. Rev Bras Méd. 2002;15:21.

NAMS Menopause practice: a clinician’sguide. USA: NAMS, 2004.

Aldrighi JM, Alecrin IN, Oliveira PR, Shinomata HO. Tabagismo e antecipação da idade da menopausa. Rev. Assoc. Med. Bras. 2005; 51(1): 51-53.

Silva Filho CR, Baracat EC, Conterno LO, Haidar MA, Ferraz MB. Sintomas climatéricos e qualidade de vida: validação do questionário da saúde da mulher. Rev Saúde Pública. 2005;39:333-9.

Freeman EW, Sammel MD, Lin H, Gracia CR, Kapoor S, Ferdousi T. The role of anxiety and hormonal changes in menopausal hot flashes. Menopause.2005;12: 258-66.

Callegari C, Buttarelli M, Cromi A, Diurni M, Salvaggio F, Bolis P. Female psychopathologic profile during menopausal transition: a preliminary study. Maturitas. 2007;56:447-51.

Tangen T, Mykletun A. Depression and anxiety through the climacteric period: an epidemiological study (HUNT-II)..J Psychosom Obstet Gynaecol. 2008;29(2):125-31.

Cunha JA. Manual da versão em português das Escalas de Beck. Casa do Psicólogo; São Paulo, 2001:171.

Matsudo SM, Araújo, TL, Matsudo VKR, Andrade DR, Andrade EL, Oliveira LC. Questionário internacional de atividade física (ipaq): estudo de validade e reprodutibilidade no Brasil. Rev Bras Ativ Saúde. 2001;10:5-18.

Souza CL. Grupos informativos sobre menopausa – informação, suporte cognitivo-comportamental e prevenção. Tese de doutorado não-publicada, Curso de Pós-graduação em Psicologia, Universidadede São Paulo, 2004.

Barlow DH. Anxiety and its disorders: the nature and treatment of anxiety and panic. 2nd ed. New York: the Guilford Press, 2002.

Almeida AB; Almeida SB. Aspectos neuropsicológicos do climatério. Rev Méd Santa Casa. 1996;7(14):1449.

Rodríguez JAP. Endocrinología clínica: publicaciones técnicas mediterráneo. Santiago de Chile. 2000.

Yonkers KA, Bradshaw K, Halbreich U. Estrogens, progestins and mood. in: Steiner M, Yonkers ka, ericson e (eds). Mood disorders in women. London, uk: martin dunitz; 2000: 207-232.

Melby MK, Lock M, Kaufert P. Culture and symptom reporting at menopause, Hum Reprod Update.2005; 11: 495-512.

Veras AB, Rassi A, Valença AM, Nardi AE. Prevalência de transtornos depressivos e ansiosos em uma amostra ambulatorial brasileira de mulheres na menopausa. Rev Psiquiatr. 2006;28:130-4.

Thomas JL, Brantley PJ. Factor structure of the center for epidemiologic studies depression scale in low-income women attending primary care clinics. Eur J Psychol Assess.2004; 0(2):106-15.

Mendito A, Cassese E, Balbi C. Climaterio e qualitá della vita. Minerva Ginecol. 1999;51:83-9.

La Rosa J. Anxiety, sex, socioeconomic status, and birth order. Psicol. Reflex. Crit. 1998;11(1):59-70.

Maevsky EI, Peskov AB, Uchitel ML, Pogorelov AG, Saharova NY, Vihlyantseva EF, et al. A succinate-based composition reverses menopausal symptoms without sex hormone replacement therapy. Adv Gerontol. 2008;21(2):298-305.

Thomas JL, Brantley PJ. Factor structure of the center for epidemiologic studies depression scale in low-income women attending primary care clinics. Eur J Psychol Assess. 2004;20(2):106-15.

Hay AG, Bancroft J, Johnstone EC. Affective symptoms in women attending menopause clinic. Br j Psychiatry.1994;164:513-6.

Gambacciani M, Ciaponi M, Cappagli B, Monteleone P, Benussi C, Bevilacqua G, et al. Effects of low-dose, continuous combined estradiol and noretisterone. Maturitas, 2003;44 (2):157-163.

Bossemeyer RP. Atividade física no climatério. In: Fernandes CE. Menopausa e tratamento. São Paulo:2003: 201-9.

Lopes FL, Nascimento I; Zin WA.Smoking and psychiatric disorders: a comorbidity survey. Braz J Med Biol Res. 2002;35(8):961-967.

Downloads

Published

2009-04-01

Issue

Vol. 19 No. 1 (2009)

Section

Original Research

License

CODE OF CONDUCT FOR JOURNAL  PUBLISHERS

 

Publishers who are Committee on Publication Ethics members and who support COPE membership for journal editors should:

 

Publishers should:

 

  • Define the relationship between publisher, editor and other parties in a contract
  • Respect privacy (for example, for research participants, for authors, for peer reviewers)
  • Protect intellectual property and copyright
  • Foster editorial independence

 

Publishers should work with journal editors to:

 

  • Set journal policies appropriately and aim to meet those policies, particularly with respect to:

–         Editorial  independence

–         Research ethics, including confidentiality, consent, and the special requirements for human and animal research

–         Authorship

–         Transparency and integrity (for example, conflicts of interest, research funding, reporting standards

–         Peer review and the role of the editorial team beyond that of the journal editor

–         Appeals and complaints

  • Communicate journal policies (for example, to authors, readers, peer reviewers)
  • Review journal policies periodically, particularly with respect to new recommendations from the COPE
  • Code of Conduct for Editors and the COPE Best Practice Guidelines
  • Maintain the integrity of the academic record
  • Assist the parties (for example, institutions, grant funders, governing bodies) responsible for the investigation of suspected research and publication misconduct and, where possible, facilitate in the resolution of these cases
  • Publish corrections, clarifications, and retractions
  • Publish content on a timely basis